Endotoxin interactions with lipopolysaccharide-responsive cells

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 476-481

  Tobias, Peter S ^a   Tapping, Richard I ^a   Gegner, Julie A ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL SURFACE RECEPTOR; ENDOTOXIN; GLYCOPROTEIN; LIPOPOLYSACCHARIDE;

BINDING AFFINITY; CELL ACTIVATION; CONFERENCE PAPER; CONFORMATION; INTERNALIZATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033020323     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515163     Document Type: Conference Paper

References (59)

1. 1. Massamiri T, Tobias PS, Curtis LK. Structural determinants for the binding of lipopolysaccharide binding protein to purified human high density lipoproteins: role of apolipoprotein A-1. J Lipid Res 1997;38:516-25.
2. 2. Wurfel MM, Wright SD. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. J Immunol 1997; 158:3925-34.
3. 3. Ishii Y, Shuyi W, Kitamura S. Soluble CD14 in serum mediates LBP-induced increase in permeability of bovine pulmonary arterial endothelial cell monolayers in vitro. Life Sci 1995;56:2263-72.
4. 4. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13:437-57.
5. 5. Ulevitch RJ, Tobias PS. Recognition of endotoxin by cells leading to transmembrane signalling. Curr Opin Immunol 1994;6:125-30.
6. 6. Hamada S, Fujiwara T, Mihara J. Bacterial endotoxic substances and their effects on host cells. In: Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, eds. Molecular pathogenesis of periodontal disease. Washington, DC: ASM Press, 1994:105-17.
7. 7. Galanos C, Luderitz O, Rietschel ET, et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 1985;148:1-5.
8. 8. Brandenburg K, Mayer H, Koch MHJ, Weckesser J, Rietschel ET, Seydel U. Influence of the supramolecular structure of free lipid A on its biological activity. Eur J Biochem 1993;218:555-63.
9. 9. Goyert SM, Ferrero EM, Seremetis SV, Winchester RJ, Silver J, Mattison AC. Biochemistry and expression of myelomonocytic antigens. J Immunol 1986;137:3909-14.
10. 10. Camussi G, Mariano F, Biancone L, et al. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 1995;155:316-24.
11. 11. Fearns C, Kravchenko VV, Ulevitch RJ, Loskutoff DJ. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 1995;181:857-66.
12. 12. Watanabe A, Takeshita A, Kitano S, Hanazawa S. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 1996;64:4488-94.
13. 13. Pugin J, Schurer-Maly C-C, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90:2744-8.
14. 14. Loppnow H, Stelter F, Schonbeck U, et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 1995;63:1020-6.
15. 15. Frey EA, Miller DS, Jahr TG, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176:1665-71.
16. 16. Verhasselt V, Buelens C, Willems F, DeGroote D, Haeffner-Cavaillon N, Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells. J Immunol 1997;158:2919-25.
17. 17. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ. Plasma lipopolysaccharide (LPS)-binding protein: a key component in macrophage recognition of gram-negative LPS. J Immunol 1992;149:200-6.
18. 18. Gegner JA, Ulevitch RJ, Tobias PS. LPS signal transduction and clearance: dual roles for LBP and mCD14. J Biol Chem 1995;270:5320-5.
19. 19. Tapping RI, Tobias PS. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem 1997;272:23157-64.
20. 20. Kitchens RL, Ulevitch RJ, Munford RS. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exp Med 1992;176:485-94.
21. 21. Schumann RR, Leong SR, Flaggs GW, et al. Structure and function of lipopolysaccharide (LPS) binding protein: a plasma protein that controls the response of macrophages to LPS. Science 1990;249:1429-31.
22. 22. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP. Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 1993;90:9935-8.
23. 23. Jack RS, Fan X, Bernheiden M, et al. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997;389:742-5.
24. 24. Tobias PS, Soldau K, Hatlen LE, et al. Lipopolysaccharide binding protein. J Cell Biochem 1992;16C:151.
25. 25. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164:777-93.
26. 26. Ramadori G, Meyer zum Buschenfelde K-H, Tobias PS, Mathison JC, Ulevitch RJ. Biosynthesis of lipopolysaccharide binding protein in rabbit hepatocytes. Pathobiology 1990;58:89-94.
27. 27. Grube BJ, Cochane CG, Ye RD, et al. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J Biol Chem 1994;269:8477-82.
28. 28. Su GL, Freeswick PD, Geller DA, et al. Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. J Immunol 1994;153:743-52.
29. 29. Wong HR, Pitt BR, Su GL, et al. Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 beta. Am J Respir Cell Mol Biol 1995;12:449-54.
30. 30. Tobias PS, Soldau K, Ulevitch RJ. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989;264:10867-71.
31. 31. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995;270:10482-8.
32. 32. Gazzano-Santoro H, Meszaros K, Birr C, et al. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infect Immun 1994;62:1185-91.
33. 33. Mészáros K, Aberle S, Dedrick R, et al. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing protein. J Clin Invest 1994;83:2516-25.
34. 34. Hailman E, Lichenstein HS, Wurfel MM, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994;179:269-77.
35. 35. Han J, Mathison J, Ulevitch R, Tobias P. Lipopolysaccharide (LPS) binding protein, truncated at Il-197, binds LPS but does not transfer LPS to CD14. J Biol Chem 1994;269:8172-5.
36. 36. Theofan G, Horwitz A, Williams R, et al. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J Immunol 1994;152:3623-9.
37. 37. Lamping N, Hoess A, Yu B, et al. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol 1996;157:4648-56.
38. 38. Hoess A, Watson S, Siber GR, Liddington R. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.4A resolution. EMBO J 1993;12:3351-6.
39. 39. Day JR, Albers JJ, Lofton-Day CE, et al. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem 1994;269:9388-91.
40. 40. Tobias PS, Mathison JC, Ulevitch RJ. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem 1988;263:13479-81.
41. 41. Gray PW, Flaggs G, Leong SR, et al. Cloning of the cDNA of a human neutrophil bactericidal protein: structural and functional correlations. J Biol Chem 1989;264:9505-9.
42. 42. Tobias PS, Soldau K, Iovine NM, Elsbach P, Weiss J. Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem 1997;272:18682-5.
43. 43. Beamer LJ, Carroll SF, Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 1997;276:1861-4.
44. 44. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14 serves as the cellular receptor for complexes of lipopolysaccharide with lipopolysaccharide binding protein. Science 1990;249:1431-3.
45. 45. Lee J-D, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J Exp Med 1992;175:1697-705.
46. 46. Ferrero E, Jiao D, Tsuberi BZ, et al. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993;90:2380-4.
47. 47. Perera P-Y, Vogel SN, Detore GR, Haziot A, Goyert SM. CD14-dependent and CD14-independent signalling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J Immunol 1997;158:4422-9.
48. 48. Pugin J, Heumann D, Tomasz A, et al. CD14 is a pattern recognition receptor. Immunity 1995;1:509-16.
49. 49. Bosco MC, Espinoza-Delgado I, Rowe TK, Malabarba MG, Longo DL, Varesio L. Functional role for the myeloid differentiation antigen CD14 in the activation of human monocytes by IL-2. J Immunol 1997;159:2922-31.
50. 50. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988;141:547-52.
51. 51. Seed B, Aruffo A. Molecular cloning of the CD1 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 1987;84:3365-9.
52. 52. Kruger C, Schutt C, Obertacke U, et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 1991; 85:297-301.
53. 53. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147:1567-4.
54. 54. Viriyakosol S, Kirkland TN. The N-terminal half of membrane CD14 is a functional cellular lipopolysaccharide receptor. Infect Immun 1996; 64:653-6.
55. 55. Juan TS, Kelley MJ, Johnson DA, et al. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J Biol Chem 1995;270:1382-7.
56. 56. Stelter F, Bernheiden M, Menzel R, et al. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur J Biochem 1997;243:100-9.
57. 57. McGinley MD, Narhi LO, Kelley MJ, et al. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. J Biol Chem 1995;270:5213-8.
58. 58. Viriyakosol S, Kirkland TN. A region of human CD14 required for lipopolysaccharide binding. J Biol Chem 1995;270:361-8.
59. 59. Lee J-D, Kravchenko V, Kirkland TN, et al. Glycosylphosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci USA 1993;90:9930-4.